| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |